HEADER VIRAL PROTEIN 10-JUL-20 7CJF TITLE CRYSTAL STRUCTURE OF SARS-COV-2 RBD IN COMPLEX WITH A NEUTRALIZING TITLE 2 ANTIBODY FAB COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANTIBODY HEAVY CHAIN; COMPND 3 CHAIN: A; COMPND 4 ENGINEERED: YES; COMPND 5 MOL_ID: 2; COMPND 6 MOLECULE: ANTIBODY LIGHT CHAIN; COMPND 7 CHAIN: B; COMPND 8 ENGINEERED: YES; COMPND 9 MOL_ID: 3; COMPND 10 MOLECULE: SPIKE PROTEIN S1; COMPND 11 CHAIN: C; COMPND 12 FRAGMENT: RECEPTOR BINDING DOMAIN, RBD; COMPND 13 SYNONYM: S GLYCOPROTEIN,E2,PEPLOMER PROTEIN,SPIKE GLYCOPROTEIN; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_TAXID: 9606; SOURCE 4 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 5 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 6 MOL_ID: 2; SOURCE 7 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 8 ORGANISM_TAXID: 9606; SOURCE 9 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 11 MOL_ID: 3; SOURCE 12 ORGANISM_SCIENTIFIC: SEVERE ACUTE RESPIRATORY SYNDROME CORONAVIRUS SOURCE 13 2; SOURCE 14 ORGANISM_COMMON: 2019-NCOV; SOURCE 15 ORGANISM_TAXID: 2697049; SOURCE 16 GENE: S, 2; SOURCE 17 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 18 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS SARS-COV-2, RBD, ANTIBODY, VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR Y.GUO,X.LI,G.ZHANG,D.FU,L.SCHWEIZER,H.ZHANG,Z.RAO REVDAT 4 29-NOV-23 7CJF 1 REMARK REVDAT 3 26-MAY-21 7CJF 1 JRNL REVDAT 2 10-MAR-21 7CJF 1 COMPND REVDAT 1 11-NOV-20 7CJF 0 JRNL AUTH Y.GUO,L.HUANG,G.ZHANG,Y.YAO,H.ZHOU,S.SHEN,B.SHEN,B.LI,X.LI, JRNL AUTH 2 Q.ZHANG,M.CHEN,D.CHEN,J.WU,D.FU,X.ZENG,M.FENG,C.PI,Y.WANG, JRNL AUTH 3 X.ZHOU,M.LU,Y.LI,Y.FANG,Y.Y.LU,X.HU,S.WANG,W.ZHANG,G.GAO, JRNL AUTH 4 F.ADRIAN,Q.WANG,F.YU,Y.PENG,A.G.GABIBOV,J.MIN,Y.WANG, JRNL AUTH 5 H.HUANG,A.STEPANOV,W.ZHANG,Y.CAI,J.LIU,Z.YUAN,C.ZHANG,Z.LOU, JRNL AUTH 6 F.DENG,H.ZHANG,C.SHAN,L.SCHWEIZER,K.SUN,Z.RAO JRNL TITL A SARS-COV-2 NEUTRALIZING ANTIBODY WITH EXTENSIVE SPIKE JRNL TITL 2 BINDING COVERAGE AND MODIFIED FOR OPTIMAL THERAPEUTIC JRNL TITL 3 OUTCOMES. JRNL REF NAT COMMUN V. 12 2623 2021 JRNL REFN ESSN 2041-1723 JRNL PMID 33976198 JRNL DOI 10.1038/S41467-021-22926-2 REMARK 2 REMARK 2 RESOLUTION. 2.11 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.14_3228 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.11 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 36.16 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 89.2 REMARK 3 NUMBER OF REFLECTIONS : 47913 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.186 REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.229 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.160 REMARK 3 FREE R VALUE TEST SET COUNT : 1991 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 36.1640 - 5.0757 0.99 3844 161 0.1599 0.1905 REMARK 3 2 5.0757 - 4.0305 1.00 3732 167 0.1271 0.1541 REMARK 3 3 4.0305 - 3.5215 0.66 2446 102 0.1948 0.2317 REMARK 3 4 3.5215 - 3.1997 1.00 3675 156 0.1798 0.2224 REMARK 3 5 3.1997 - 2.9705 1.00 3670 159 0.1990 0.2549 REMARK 3 6 2.9705 - 2.7954 1.00 3675 159 0.2023 0.2402 REMARK 3 7 2.7954 - 2.6555 1.00 3669 154 0.2077 0.2865 REMARK 3 8 2.6555 - 2.5399 1.00 3643 157 0.2125 0.3158 REMARK 3 9 2.5399 - 2.4422 1.00 3612 157 0.2185 0.2699 REMARK 3 10 2.4422 - 2.3579 0.99 3607 159 0.2295 0.2702 REMARK 3 11 2.3579 - 2.2842 0.96 3519 156 0.2357 0.2930 REMARK 3 12 2.2842 - 2.2189 0.22 788 33 0.3292 0.4314 REMARK 3 13 2.2189 - 2.1605 0.88 3160 142 0.2470 0.2889 REMARK 3 14 2.1605 - 2.1080 0.79 2882 129 0.2236 0.2464 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.260 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 24.040 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.14 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : NULL NULL REMARK 3 ANGLE : NULL NULL REMARK 3 CHIRALITY : NULL NULL REMARK 3 PLANARITY : NULL NULL REMARK 3 DIHEDRAL : NULL NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: ALL REMARK 3 ORIGIN FOR THE GROUP (A): 1.5016 -32.9337 -5.5220 REMARK 3 T TENSOR REMARK 3 T11: 0.1721 T22: 0.2342 REMARK 3 T33: 0.2128 T12: 0.0113 REMARK 3 T13: -0.0112 T23: -0.0038 REMARK 3 L TENSOR REMARK 3 L11: 0.0671 L22: 0.8778 REMARK 3 L33: 0.5250 L12: 0.1611 REMARK 3 L13: -0.1233 L23: -0.4499 REMARK 3 S TENSOR REMARK 3 S11: -0.0042 S12: -0.0398 S13: -0.0227 REMARK 3 S21: -0.1182 S22: 0.0032 S23: 0.0425 REMARK 3 S31: 0.0764 S32: 0.0253 S33: 0.0010 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 7CJF COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 13-JUL-20. REMARK 100 THE DEPOSITION ID IS D_1300017714. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-JUN-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9790 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 49623 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 92.7 REMARK 200 DATA REDUNDANCY : 9.600 REMARK 200 R MERGE (I) : 0.09100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 7.9000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.14 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.8 REMARK 200 DATA REDUNDANCY IN SHELL : 9.70 REMARK 200 R MERGE FOR SHELL (I) : 0.80000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 7BWJ REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 62.94 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.32 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20%(W/V)PEG 3350 0.2M POTASSIUM REMARK 280 CITRATE TRIBASIC, EVAPORATION, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 2 2 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -X,Y,-Z+1/2 REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 72.32750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 72.32750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 42.97900 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 74.28750 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 42.97900 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 74.28750 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 72.32750 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 42.97900 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 74.28750 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 72.32750 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 42.97900 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 74.28750 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 6040 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 27650 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -21.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH C 775 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 221 REMARK 465 PRO A 222 REMARK 465 PRO A 223 REMARK 465 CYS A 224 REMARK 465 PRO A 225 REMARK 465 PRO A 226 REMARK 465 CYS A 227 REMARK 465 PRO A 228 REMARK 465 CYS B 214 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 GLN A 100 -140.72 52.74 REMARK 500 SER A 104 -156.79 55.98 REMARK 500 ARG A 134 83.06 -66.37 REMARK 500 SER A 137 -111.45 34.01 REMARK 500 SER A 139 1.70 89.33 REMARK 500 ASP A 149 60.46 66.22 REMARK 500 SER B 30 -123.80 51.21 REMARK 500 ALA B 51 -42.65 69.02 REMARK 500 ALA B 84 -179.12 -177.31 REMARK 500 PRO B 95 35.73 -97.98 REMARK 500 PHE C 377 87.77 -152.54 REMARK 500 PHE C 400 171.41 177.45 REMARK 500 ASN C 422 -57.73 -127.31 REMARK 500 ASP C 428 33.00 -98.67 REMARK 500 ASN C 481 62.31 27.40 REMARK 500 ASN C 487 19.28 59.59 REMARK 500 CYS C 525 -51.58 -120.09 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH C 865 DISTANCE = 5.93 ANGSTROMS REMARK 525 HOH C 866 DISTANCE = 10.20 ANGSTROMS DBREF 7CJF A 1 228 PDB 7CJF 7CJF 1 228 DBREF 7CJF B 1 214 PDB 7CJF 7CJF 1 214 DBREF 7CJF C 334 527 UNP P0DTC2 SPIKE_SARS2 334 527 SEQRES 1 A 228 GLU VAL GLN LEU VAL GLU SER GLY GLY GLY LEU ILE GLN SEQRES 2 A 228 PRO GLY GLY SER LEU ARG LEU SER CYS ALA ALA SER GLY SEQRES 3 A 228 PHE ILE VAL SER SER ASN TYR MET SER TRP VAL ARG GLN SEQRES 4 A 228 ALA PRO GLY LYS GLY LEU GLU TRP VAL SER ILE ILE TYR SEQRES 5 A 228 SER GLY GLY SER THR PHE TYR ALA ASP SER VAL LYS GLY SEQRES 6 A 228 ARG PHE THR ILE SER ARG ASP ASN SER LYS ASN THR LEU SEQRES 7 A 228 TYR LEU GLN MET ASN SER LEU ARG VAL GLU ASP THR ALA SEQRES 8 A 228 VAL TYR TYR CYS ALA ARG ASP LEU GLN GLU LEU GLY SER SEQRES 9 A 228 LEU ASP TYR TRP GLY GLN GLY THR LEU VAL THR VAL SER SEQRES 10 A 228 SER ALA SER THR LYS GLY PRO SER VAL PHE PRO LEU ALA SEQRES 11 A 228 PRO CYS SER ARG SER THR SER GLU SER THR ALA ALA LEU SEQRES 12 A 228 GLY CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO VAL THR SEQRES 13 A 228 VAL SER TRP ASN SER GLY ALA LEU THR SER GLY VAL HIS SEQRES 14 A 228 THR PHE PRO ALA VAL LEU GLN SER SER GLY LEU TYR SER SEQRES 15 A 228 LEU SER SER VAL VAL THR VAL PRO SER SER SER LEU GLY SEQRES 16 A 228 THR LYS THR TYR THR CYS ASN VAL ASP HIS LYS PRO SER SEQRES 17 A 228 ASN THR LYS VAL ASP LYS ARG VAL GLU SER LYS TYR GLY SEQRES 18 A 228 PRO PRO CYS PRO PRO CYS PRO SEQRES 1 B 214 ASP ILE GLN MET THR GLN SER PRO SER SER VAL SER ALA SEQRES 2 B 214 SER VAL GLY ASP ARG VAL THR ILE THR CYS ARG ALA SER SEQRES 3 B 214 GLN GLY ILE SER SER TRP LEU ALA TRP TYR GLN GLN LYS SEQRES 4 B 214 PRO GLY LYS ALA PRO LYS LEU LEU ILE TYR ALA ALA SER SEQRES 5 B 214 SER LEU GLN SER GLY VAL PRO SER ARG PHE SER GLY SER SEQRES 6 B 214 GLY SER GLY THR ASP PHE THR LEU THR ILE SER SER LEU SEQRES 7 B 214 GLN PRO GLU ASP PHE ALA THR TYR TYR CYS GLN GLU ALA SEQRES 8 B 214 ASN SER PHE PRO TYR THR PHE GLY GLN GLY THR LYS LEU SEQRES 9 B 214 GLU ILE LYS ARG THR VAL ALA ALA PRO SER VAL PHE ILE SEQRES 10 B 214 PHE PRO PRO SER ASP GLU GLN LEU LYS SER GLY THR ALA SEQRES 11 B 214 SER VAL VAL CYS LEU LEU ASN ASN PHE TYR PRO ARG GLU SEQRES 12 B 214 ALA LYS VAL GLN TRP LYS VAL ASP ASN ALA LEU GLN SER SEQRES 13 B 214 GLY ASN SER GLN GLU SER VAL THR GLU GLN ASP SER LYS SEQRES 14 B 214 ASP SER THR TYR SER LEU SER SER THR LEU THR LEU SER SEQRES 15 B 214 LYS ALA ASP TYR GLU LYS HIS LYS VAL TYR ALA CYS GLU SEQRES 16 B 214 VAL THR HIS GLN GLY LEU SER SER PRO VAL THR LYS SER SEQRES 17 B 214 PHE ASN ARG GLY GLU CYS SEQRES 1 C 194 ASN LEU CYS PRO PHE GLY GLU VAL PHE ASN ALA THR ARG SEQRES 2 C 194 PHE ALA SER VAL TYR ALA TRP ASN ARG LYS ARG ILE SER SEQRES 3 C 194 ASN CYS VAL ALA ASP TYR SER VAL LEU TYR ASN SER ALA SEQRES 4 C 194 SER PHE SER THR PHE LYS CYS TYR GLY VAL SER PRO THR SEQRES 5 C 194 LYS LEU ASN ASP LEU CYS PHE THR ASN VAL TYR ALA ASP SEQRES 6 C 194 SER PHE VAL ILE ARG GLY ASP GLU VAL ARG GLN ILE ALA SEQRES 7 C 194 PRO GLY GLN THR GLY LYS ILE ALA ASP TYR ASN TYR LYS SEQRES 8 C 194 LEU PRO ASP ASP PHE THR GLY CYS VAL ILE ALA TRP ASN SEQRES 9 C 194 SER ASN ASN LEU ASP SER LYS VAL GLY GLY ASN TYR ASN SEQRES 10 C 194 TYR LEU TYR ARG LEU PHE ARG LYS SER ASN LEU LYS PRO SEQRES 11 C 194 PHE GLU ARG ASP ILE SER THR GLU ILE TYR GLN ALA GLY SEQRES 12 C 194 SER THR PRO CYS ASN GLY VAL GLU GLY PHE ASN CYS TYR SEQRES 13 C 194 PHE PRO LEU GLN SER TYR GLY PHE GLN PRO THR ASN GLY SEQRES 14 C 194 VAL GLY TYR GLN PRO TYR ARG VAL VAL VAL LEU SER PHE SEQRES 15 C 194 GLU LEU LEU HIS ALA PRO ALA THR VAL CYS GLY PRO HET NAG C 601 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 4 NAG C8 H15 N O6 FORMUL 5 HOH *591(H2 O) HELIX 1 AA1 ILE A 28 ASN A 32 5 5 HELIX 2 AA2 ASN A 73 LYS A 75 5 3 HELIX 3 AA3 ARG A 86 THR A 90 5 5 HELIX 4 AA4 LEU A 99 SER A 104 1 6 HELIX 5 AA5 SER A 161 ALA A 163 5 3 HELIX 6 AA6 SER A 192 LEU A 194 5 3 HELIX 7 AA7 LYS A 206 ASN A 209 5 4 HELIX 8 AA8 GLN B 79 PHE B 83 5 5 HELIX 9 AA9 SER B 121 SER B 127 1 7 HELIX 10 AB1 LYS B 183 GLU B 187 1 5 HELIX 11 AB2 PRO C 337 ASN C 343 1 7 HELIX 12 AB3 SER C 349 TRP C 353 5 5 HELIX 13 AB4 TYR C 365 ASN C 370 1 6 HELIX 14 AB5 PRO C 384 LEU C 390 5 7 HELIX 15 AB6 ASP C 405 ILE C 410 5 6 HELIX 16 AB7 GLY C 416 ASN C 422 1 7 HELIX 17 AB8 SER C 438 SER C 443 1 6 HELIX 18 AB9 GLY C 502 TYR C 505 5 4 SHEET 1 AA1 4 GLN A 3 SER A 7 0 SHEET 2 AA1 4 LEU A 18 SER A 25 -1 O SER A 21 N SER A 7 SHEET 3 AA1 4 THR A 77 MET A 82 -1 O MET A 82 N LEU A 18 SHEET 4 AA1 4 PHE A 67 ASP A 72 -1 N THR A 68 O GLN A 81 SHEET 1 AA2 6 LEU A 11 ILE A 12 0 SHEET 2 AA2 6 THR A 112 VAL A 116 1 O THR A 115 N ILE A 12 SHEET 3 AA2 6 ALA A 91 ASP A 98 -1 N TYR A 93 O THR A 112 SHEET 4 AA2 6 TYR A 33 GLN A 39 -1 N VAL A 37 O TYR A 94 SHEET 5 AA2 6 LEU A 45 ILE A 51 -1 O VAL A 48 N TRP A 36 SHEET 6 AA2 6 THR A 57 TYR A 59 -1 O PHE A 58 N ILE A 50 SHEET 1 AA3 4 LEU A 11 ILE A 12 0 SHEET 2 AA3 4 THR A 112 VAL A 116 1 O THR A 115 N ILE A 12 SHEET 3 AA3 4 ALA A 91 ASP A 98 -1 N TYR A 93 O THR A 112 SHEET 4 AA3 4 LEU A 105 TRP A 108 -1 O TYR A 107 N ARG A 97 SHEET 1 AA4 4 SER A 125 LEU A 129 0 SHEET 2 AA4 4 THR A 140 TYR A 150 -1 O LEU A 146 N PHE A 127 SHEET 3 AA4 4 TYR A 181 PRO A 190 -1 O LEU A 183 N VAL A 147 SHEET 4 AA4 4 VAL A 168 THR A 170 -1 N HIS A 169 O VAL A 186 SHEET 1 AA5 4 SER A 125 LEU A 129 0 SHEET 2 AA5 4 THR A 140 TYR A 150 -1 O LEU A 146 N PHE A 127 SHEET 3 AA5 4 TYR A 181 PRO A 190 -1 O LEU A 183 N VAL A 147 SHEET 4 AA5 4 VAL A 174 LEU A 175 -1 N VAL A 174 O SER A 182 SHEET 1 AA6 3 THR A 156 TRP A 159 0 SHEET 2 AA6 3 TYR A 199 HIS A 205 -1 O ASN A 202 N SER A 158 SHEET 3 AA6 3 THR A 210 VAL A 216 -1 O VAL A 212 N VAL A 203 SHEET 1 AA7 4 MET B 4 SER B 7 0 SHEET 2 AA7 4 VAL B 19 ALA B 25 -1 O ARG B 24 N THR B 5 SHEET 3 AA7 4 ASP B 70 ILE B 75 -1 O LEU B 73 N ILE B 21 SHEET 4 AA7 4 PHE B 62 GLY B 66 -1 N SER B 63 O THR B 74 SHEET 1 AA8 6 SER B 10 ALA B 13 0 SHEET 2 AA8 6 THR B 102 ILE B 106 1 O LYS B 103 N VAL B 11 SHEET 3 AA8 6 THR B 85 GLU B 90 -1 N TYR B 86 O THR B 102 SHEET 4 AA8 6 LEU B 33 GLN B 38 -1 N TYR B 36 O TYR B 87 SHEET 5 AA8 6 LYS B 45 TYR B 49 -1 O LEU B 47 N TRP B 35 SHEET 6 AA8 6 SER B 53 LEU B 54 -1 O SER B 53 N TYR B 49 SHEET 1 AA9 4 SER B 114 PHE B 118 0 SHEET 2 AA9 4 THR B 129 PHE B 139 -1 O LEU B 135 N PHE B 116 SHEET 3 AA9 4 TYR B 173 SER B 182 -1 O LEU B 179 N VAL B 132 SHEET 4 AA9 4 SER B 159 VAL B 163 -1 N SER B 162 O SER B 176 SHEET 1 AB1 4 ALA B 153 LEU B 154 0 SHEET 2 AB1 4 ALA B 144 VAL B 150 -1 N VAL B 150 O ALA B 153 SHEET 3 AB1 4 VAL B 191 HIS B 198 -1 O GLU B 195 N GLN B 147 SHEET 4 AB1 4 VAL B 205 ASN B 210 -1 O VAL B 205 N VAL B 196 SHEET 1 AB2 5 ASN C 354 ILE C 358 0 SHEET 2 AB2 5 ASN C 394 ARG C 403 -1 O VAL C 395 N ILE C 358 SHEET 3 AB2 5 PRO C 507 GLU C 516 -1 O VAL C 512 N ASP C 398 SHEET 4 AB2 5 GLY C 431 ASN C 437 -1 N ILE C 434 O VAL C 511 SHEET 5 AB2 5 THR C 376 TYR C 380 -1 N TYR C 380 O GLY C 431 SHEET 1 AB3 2 LEU C 452 ARG C 454 0 SHEET 2 AB3 2 LEU C 492 SER C 494 -1 O GLN C 493 N TYR C 453 SHEET 1 AB4 2 TYR C 473 GLN C 474 0 SHEET 2 AB4 2 CYS C 488 TYR C 489 -1 O TYR C 489 N TYR C 473 SSBOND 1 CYS A 22 CYS A 95 1555 1555 2.04 SSBOND 2 CYS A 145 CYS A 201 1555 1555 2.02 SSBOND 3 CYS B 23 CYS B 88 1555 1555 2.06 SSBOND 4 CYS B 134 CYS B 194 1555 1555 2.01 SSBOND 5 CYS C 336 CYS C 361 1555 1555 2.03 SSBOND 6 CYS C 379 CYS C 432 1555 1555 2.06 SSBOND 7 CYS C 391 CYS C 525 1555 1555 2.04 SSBOND 8 CYS C 480 CYS C 488 1555 1555 2.06 LINK ND2 ASN C 343 C1 NAG C 601 1555 1555 1.45 CISPEP 1 PHE A 151 PRO A 152 0 -4.85 CISPEP 2 GLU A 153 PRO A 154 0 -0.15 CISPEP 3 SER B 7 PRO B 8 0 -6.70 CISPEP 4 PHE B 94 PRO B 95 0 -0.58 CISPEP 5 TYR B 140 PRO B 141 0 3.74 CRYST1 85.958 148.575 144.655 90.00 90.00 90.00 C 2 2 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011634 0.000000 0.000000 0.00000 SCALE2 0.000000 0.006731 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006913 0.00000